European Medicines Agency [to 10 September 2016]
Fighting antimicrobial resistance globally
EMA, FDA and PMDA discuss regulatory approaches for the evaluation of new antibacterial agents
NIH [to 10 September 2016]
September 8, 2016
Federal prize competition seeks innovative ideas to combat antimicrobial resistance
Contestants will vie for $20 million in prizes to develop new innovative laboratory diagnostic tools that detect and distinguish antibiotic resistant bacteria.
NCI embraces scientific road map to achieve Cancer Moonshot goals
September 7, 2016 — Blue Ribbon Panel outlines 10 transformative approaches for accelerating progress against cancer.
FDA [to 10 September 2016]
What’s New for Biologics
:: Influenza Virus Vaccine for the 2016-2017 Season Posted: 9/7/2016
:: Public Hearing; Request for Comments – Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products
Updated to include a link to the webcast; Updated: 9/8/2016
:: Statistical Review – Afluria Quadrivalent (PDF – 251KB) Posted: 9/6/2016
:: Clinical Review – Afluria Quadrivalent (PDF – 587KB) Posted: 9/6/2016
:: Final Agenda: Part 15 Hearing: Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products Updated: 9/6/2016
European Vaccine Initiative [to 10 September 2016]
EVI Annual Report 2015 now available
09 September 2016
The EVI 2015 Annual Report provides a detailed insight into all of EVI’s activities, projects, important meetings etc. We hope you will find it not only enlightening, but interesting reading.
New publication emanating from EVI project AMA1
08 September 2016
New article published on 30 August 2016 in Malaria Journal emanating from EVI project AMA1
Fondation Merieux [to 10 September 2016]
Mission: Contribute to global health by strengthening local capacities of developing countries to reduce the impact of infectious diseases on vulnerable populations.
7 September 2016, Lyon (France)
“Better Foods for Better Health” White Book: 30 global experts share the latest findings on microbiota in disease prevention and obesity
The 5th edition of the Better Foods for Better Health White Book has been published, providing new insight from 30 thought leaders from science and industry on the growing role and potential of gut microbiota to improve health.
EDCTP [to 10 September 2016]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
6 September 2016
Notice of voluntary liquidation of EDCTP-EEIG (legal structure for the first EDCTP programme, 2003-2015)
The EDCTP-EEIG, the legal structure for the first EDCTP programme (2003-2015), is in liquidation (Dutch: in liquidatie). The EDCTP-EEIG was incorporated for the implementation of the activities set out in the contract signed between the EDCTP-EEIG and the European Commission. Following the successful completion of the first programme, the EDCTP-EEIG General Assembly approved on 3 June 2016 the complete liquidation of the EDCTP-EEIG legal entity and the winding up of its affairs…